12:00 AM
 | 
Sep 03, 2002
 |  BioCentury  |  Strategy

MedImmune's pipeline

MedImmune's pipeline

Product Indication Status
Synagis palivizumab RSV Mkt
Ethyol amifostine Chemoprotection Mkt
...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >